HAE GLOBAL CONFERENCES
The largest international gathering with a focus on HAE topics
Every second year HAEi welcomes HAE patients, caregivers, health care professionals, and industry representatives to the HAE Global Conference – the largest international gathering of its kind solely with a focus on HAE topics. At the conferences, the participants learn much more about HAE as they share experiences and knowledge in a friendly atmosphere conducted and driven by the patient community organized in HAEi.
The first HAE Global Conference took place in Copenhagen, Denmark in 2012, followed by Washington D.C., USA in 2014 and Madrid, Spain in 2016. Most recently the HAE Global Conference took place in Vienna, Austria in May 2018.
The 2020 HAE Global Conference takes place in Frankfurt, Germany in May 2020 – read much more here.
Visit the highlight site for the 2018 HAE Global Conference here.
Dates: 17-20 May 2018
Venue: Vienna, Austria
Theme: Take Control of HAE
Attendees: Approx. 735
Scientific Program Committee:
Prof. Marco Cicardi (Italy), Prof. Konrad Bork (Germany), Prof. Bruce Zuraw (USA), Prof. Anete S. Grumach (Brazil), Prof. Bruce Ritchie (Canada), Prof. Connie Katelaris (Australia), Prof. Henriette Farkas (Hungary), Dr. Hilary Longhurst (United Kingdom), Dr. Isao Ohsawa (Japan), Prof. Marc Riedl (USA), Prof. Markus Magerl (Germany), and Dr. Teresa Caballero (Spain).
Keynote speakers:
1: “Take Control: Don’t let HAE hold you back” – Mr. Y. Yamamoto
2: “Take Control of HAE with Real-World Data” – Prof. M. Cicardi
3: “Take Control of HAE – New Advances and Approaches” – Prof. A. Kaplan
4: “Take Control: Dealing with Public Authorities” – Minister of Health V. Filipce
5: “Take Control: The Science of Improving HAE Care” – Prof. B. Zuraw
6: “Take Control: The Science of Improving HAE Care” – Prof. K. Bork
7: “Take Control: The Science of Improving HAE Care” – Prof. M. Cicardi
8: “Take Control: Stay Motivated” – Mr. M. Anthony
9: “Take Control: Now and the future” – Prof. M. Riedl
10: “Take Control: Now and the future” – M. Magerl
Diamond Sponsor:
CSL Behring
Shire
Gold Sponsors:
BioCryst Pharmaceuticals
Pharming Group
Basic Sponsor:
KalVista Pharmaceuticals
Dates: 19-22 May 2016
Venue: Madrid, Spain
Theme: Creative Advocacy for Expanding Access to Therapy
Attendees: Approx. 525
President of Honor:
Her Majesty Queen Letizia of Spain
Scientific Program Committee:
Prof. Marco Cicardi (Italy), Prof. Bruce Zuraw (USA), Prof. Konrad Bork (Germany), Prof. Markus Magerl (Germany), Prof. Marc Riedl (USA), Prof. Henriette Farkas (Hungary), Dr. Teresa Caballero (Spain), Dr. Hilary Longhurst (United Kingdom), Prof. Connie Katelaris (Australia), Prof. Anete Grumach (Brazil), Dr. Isao Osawa (Japan), and Dr. Sulaiman Al Gazlan (Saudi Arabia)
Keynote speakers:
1: “Improving HAE Diagnosis”, Prof. M. Cicardi
2. “Improving HAE Care”, Dr. T. Caballero
3: “Creative Advocacy for Expanding Access to Therapy”, Mr. A. J. Castaldo
4: “Experiences from Hemophilia and the Importance of Patient Advocacy”, Mr. M. Skinner
5: “Juggling with Genes for Cellular Modeling and Therapy of HAE”, Prof. J. Giehm Mikkelsen
Diamond Sponsor:
Shire
Gold Sponsors:
BioCryst Pharmaceuticals
CSL Behring
Silver Sponsor:
Pharming Group NV/Sobi
Basic Sponsor:
KalVista Pharmaceuticals
Dates: 15-18 May 2014
Venue: Washington D.C., USA
Theme: Setting New Standards
Attendees: Approx. 450
Scientific Program Committee:
Prof. Marco Cicardi (Italy), Prof. Bruce Zuraw (USA), Prof. Konrad Bork (Germany), Prof. Wolfhart Kreuz (Germany), Assoc. Prof. Marc Riedl (USA), Prof. Henriette Farkas (Hungary), Dr. Alejandro Malbrán (Argentina), Dr. Hilary Longhurst (United Kingdom), Dr. Andrea Zanichelli (Italy), and Dr. Mar Guilarte (Spain)
Keynote speakers:
1: “Because it’s Personal”, Mr. A. J. Castaldo
2: “HAE – A Scientific-Medical Perspective”, Dr. B. Zuraw
3: “HAE – A Historical Perspective”, Dr. M. Frank
4: “The Challenges Treating Children and Women with HAE”, Dr. H. Farkas
5: “HAE in the Future”, Dr. A. Banerji
Diamond Sponsors:
Shire
ViroPharma
Gold Sponsor:
CSL Behring
Silver Sponsor:
Dyax Corp.
Basic Sponsors:
BioCryst Pharmaceuticals
Salix Pharmaceuticals
Dates: 17-20 May 2012
Venue: Copenhagen, Denmark
Theme: Advocacy and Awareness
Attendees: Approx. 350
Scientific Program Committee:
Prof. Marco Cicardi (Italy), Prof. Bruce Zuraw (USA), Prof. Konrad Bork (Germany), Prof. Connie Katelaris (Australia), Assoc. Prof. Marc Riedl (USA), Assoc. Professor Anette Bygum (Denmark), Dr. Teresa Caballero (Spain), and Dr. Anete S. Grumach (Brazil)
Keynote speakers:
1: “Taking care of patients from 1886 until 2012”, Prof. M. Cicardi
2: “HAE Global Advocacy: The key to better quality of life”, Mr. A. J. Castaldo
3: “Reimbursement of medication and handling regulatory authorities”, Mrs. B. Byskov Holm, EURORDIS
4: “The future of HAE patients. A physicians perspective”, Assoc. Prof. M. Riedl
Diamond Sponsors:
ViroPharma Incorporated
Shire Human Genetic Therapies
Gold Sponsors:
CSL Behring
Dyax/Sigma-Tau
Silver Sponsor:
Sobi –Swedish Orphan Biovitrum
HAE related topics that might interest you
Global Access Program
Helping to change the lives of patients with hereditary angioedema (HAE) with a medication access program
Global Perspectives
Magazine with timely information on the issues, activities, and events that are relevant to the global HAE community
HAEi Connect Member database
Free, secure online membership database and communications platform for HAEi’s member organizations
Regional Patient Advocates
Constantly strive to improve the situation for HAE friends all over the world – no matter how they are organized
Stay tuned – sign up for our newsletter
BE THE FIRST TO KNOW ABOUT HAE NEWS, TREATMENTS, EVENTS AND RELATED TOPICS